本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

TC BioPharm

0.5000
+0.0000
成交量:- -
成交額:- -
市值:25.65萬
市盈率:-0.01
高:0.5000
開:0.5000
低:0.5000
收:0.5000
資料載入中...
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/06

重要事件披露

Form 8-K - Current report
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/15

SEC問詢函

Form CORRESP - Correspondence
2023/12/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/12/13

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/11/02

SEC問詢函

Form CORRESP - Correspondence
2023/08/29

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/05/01

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/27

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2023/03/23

SEC問詢函

CORRESP [Cover] - Correspondence
2023/03/23

招股説明書

F-1 - Registration statement for certain foreign private issuers
2023/02/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/21

SEC問詢函

CORRESP [Cover] - Correspondence